Literature DB >> 33578297

Prevalence and charges of opioid-related visits to U.S. emergency departments.

James R Langabeer1, Angela L Stotts2, Bentley J Bobrow3, Henry E Wang3, Kimberly A Chambers3, Andrea J Yatsco4, Marylou Cardenas-Turanzas4, Tiffany Champagne-Langabeer4.   

Abstract

OBJECTIVE: An overwhelming responsibility for responding to the opioid epidemic falls on hospital emergency departments (ED). We sought to examine the overall prevalence rate and associated charges of opioid-related diagnoses and overdoses. Although charge data do not necessarily represent cost, they are proxy indicators of resource utilization and burden.
METHODS: We conducted a retrospective study of the National Emergency Department Sample (NEDS) dataset, the largest all-payer ED database in the United States. We queried using specific relevant ICD-10 codes to estimate the number of adult ED visits for both opioid poisonings and other opioid-related diagnoses during 2016 and 2017, which was the most recent publicly available data. Prevalence rates and financial charges were calculated by year and odds ratios were used to examine differences.
RESULTS: Of approximately 234 million adult visits to EDs across 2016 and 2017, 2.88 million (1.23%) were related to opioids, with overdoses comprising nearly 27.5% and visits for other opioid-related diagnoses totaling 72.5%. As the primary diagnosis, opioids were responsible for 37% of all ED visits across both years. Total opioid-related visits for the two years accounted for $9.57 billion in ED charges, or $4.78 billion annually, with Medicaid and Medicare responsible for 66% of all charges. CONCLUSION AND RELEVANCE: Approximately one of every 80 visits to the ED were opioid-related, leading to financial charges approaching $5 billion per year. Since both prevalence and the economic burden of opioid-related visits are high, targeted interventions to address this epidemic's impact on healthcare systems should be a national priority.
Copyright © 2021 Elsevier B.V. All rights reserved.

Keywords:  Costs; Emergency department; Epidemiology; Opioid use disorder; Overdose

Year:  2021        PMID: 33578297     DOI: 10.1016/j.drugalcdep.2021.108568

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  4 in total

1.  External validation of an opioid misuse machine learning classifier in hospitalized adult patients.

Authors:  Majid Afshar; Brihat Sharma; Sameer Bhalla; Hale M Thompson; Dmitriy Dligach; Randy A Boley; Ekta Kishen; Alan Simmons; Kathryn Perticone; Niranjan S Karnik
Journal:  Addict Sci Clin Pract       Date:  2021-03-17

2.  Feasibility and outcomes from an integrated bridge treatment program for opioid use disorder.

Authors:  James R Langabeer; Tiffany Champagne-Langabeer; Andrea J Yatsco; Meredith M O'Neal; Marylou Cardenas-Turanzas; Samuel Prater; Samuel Luber; Angela Stotts; Tom Fadial; Gina Khraish; Henry Wang; Bentley J Bobrow; Kimberly A Chambers
Journal:  J Am Coll Emerg Physicians Open       Date:  2021-03-31

3.  Opioid usage and COVID-19 prognosis: A systematic review and meta-analysis.

Authors:  Guangyu Ao; Anthony Li; Yushu Wang; Jing Li; Carolyn Tran; Min Chen; Xin Qi
Journal:  Am J Emerg Med       Date:  2022-03-27       Impact factor: 4.093

4.  The Identification of Subphenotypes and Associations with Health Outcomes in Patients with Opioid-Related Emergency Department Encounters Using Latent Class Analysis.

Authors:  Neeraj Chhabra; Dale L Smith; Caitlin M Maloney; Joseph Archer; Brihat Sharma; Hale M Thompson; Majid Afshar; Niranjan S Karnik
Journal:  Int J Environ Res Public Health       Date:  2022-07-21       Impact factor: 4.614

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.